[Other] PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/

LubnaSharif2 Post time 3 day(s) ago | Show all posts |Read mode
Reward23points

journal:Journal of Clinical Oncology

Authors:Erica L. Mayer; Yue Ren; Nikhil Wagle; Reshma Mahtani; Cynthia Ma; Angela DeMichele; Massimo Cristofanilli; Jane Meisel; Kathy D. Miller; Yara Abdou; Elizabeth C. Riley; Rubina Qamar; Priyanka Sharma; Sonya Reid; Natalie Sinclair; Meredith Faggen; Caroline C. Block; Naomi Ko; Ann H. Partridge; Wendy Y. Chen; Michelle DeMeo; Victoria Attaya; Amanda Okpoebo; Jillian Alberti; Yuan Liu; Eric Gauthier; Harold J. Burstein; Meredith M. Regan; Sara M. Tolaney

Published date:2024-6-10

DOI:10.1200/jco.23.01940

PDF link:https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.01940

Article link:http://dx.doi.org/10.1200/jco.23.01940

Article Source:American Society of Clinical Oncology (ASCO)


Remark:URGENT HELP
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    11205

Latest Reply

Return to the list